FDA Expects To Finish Several EU GMP Equivalency Determinations in 3 Years
This article was originally published in The Tan Sheet
Executive Summary
FDA expects to complete equivalency determinations for two or three countries during the three-year transition period established under the European Union-US. mutual recognition agreement on Good Manufacturing Practices, FDA Deputy Commissioner for External Affairs Sharon Smith Holston told a House Commerce/Oversight Subcommittee hearing Oct. 2.